EXCLUSIVE

Home visits are the key to patient retention, says ResearchNurses.co

By Natalie Morrison

- Last updated on GMT

Related tags: Patient, Health care

Home visits are the key to patient retention, says ResearchNurses.co
Including home visits in clinical trial designs could be the key to patient retention, according to ResearchNurses.co.

The UK-based research nurse provider says that by providing a regular, trusted point of contact to help administer the drugs and deal with the finer details, participants are much more likely to stay in the trial.

Other benefits, says the firm, include improved patient compliance – because a trained healthcare professional is there to help administer the drug and ensure trial data is completed accurately – as well as initial clinical assessments performed before samples hit the lab.

Speaking to Outsourcing-Pharma, Sue Mackay, research nursing team manager, said: “If it does mean that we’re getting perfect data that is absolutely clean, we’re getting patient compliance and retention within the studies then in the long run that is going to benefit people.”

False economy?

Mackay added that, although the initial outlay for such individualised patient care is higher than having the patient come to the research centre, in the long-run it saves money.

To me it’s a bit of a double edge sword​,” she said. “It’s one thing to recruit patients but it’s another to retain them. It would cost more to recruit all over again.

She added: “I think a lot of studies are beginning to look quite seriously at home care studies, especially for long-term diseases.”

Part II of the podcast coming up tomorrow. Mackay discusses the regulatory benefits, and changing views of Big Pharma towards home visits.

Related news

Show more

Related products

show more

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 16-Jan-2023 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

PPD - Decentralized Clinical Trials | 12-Jan-2023 | Technical / White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are...

PPD is Supporting Complex EU DCTs

PPD is Supporting Complex EU DCTs

PPD - Decentralized Clinical Trials | 05-Jan-2023 | Technical / White Paper

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 14-Dec-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars